FDA NDA · NDA211913
ABSORICA LD
isotretinoin
Sponsor: SUN PHARM
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
NDA211913
TYPE
NDA
ORIGINAL APPROVAL
2019-11-05
LATEST ACTION
2026-10-07
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued, Prescription
Products
ABSORICA LD · ReferenceDiscontinued
ISOTRETINOIN 28MG · CAPSULE · ORAL
ABSORICA LD · ReferenceDiscontinued
ISOTRETINOIN 20MG · CAPSULE · ORAL
ABSORICA LD · ReferencePrescription
ISOTRETINOIN 8MG · CAPSULE · ORAL
ABSORICA LD · ReferencePrescription
ISOTRETINOIN 32MG · CAPSULE · ORAL
ABSORICA LD · ReferencePrescription
ISOTRETINOIN 24MG · CAPSULE · ORAL
ABSORICA LD · ReferencePrescription
ISOTRETINOIN 16MG · CAPSULE · ORAL
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →